1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
CEN Biotech, Inc.

CEN Biotech, Inc.

CENBF
CEN Biotech, Inc.US flagOther OTC
0.00
USD
- -
- -
6,526.00Market Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
0.01
0.02
0.02
Basic EPS, GAAP
-12.68
-0.34
-1.2
-1.68
-0.3
-0.21
0.52
-0.45
-0.02
-0.03
Free Cash Flow per Basic Share
-46.02
-0.04
-0.1
-0.28
-0.07
-0.03
-0.01
-0.01
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-13.64
-0.83
-2.05
-3.35
-1.41
-1.57
-0.99
-1.08
-0.73
-0.75
Tangible Book Value per Share
-13.64
-0.83
-3.02
-3
-1.07
-1.17
-0.55
-0.19
-0.13
-0.14
Basic Weighted Avg Shares
- -
7
7
8
25
26
27
42
65
64
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
1
1
1
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
-2,824.48
-128.14
-137.81
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-3
-2
-8
-14
-8
-6
14
-19
-2
-2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
-3,015.58
-153.46
-151.4
Working Capital
-11
-13
-15
-20
-24
-31
-15
-9
-10
-10
LT Debt
1
1
3
3
3
1
- -
- -
- -
- -
Total Equity
-3
-6
-14
-19
-21
-26
-10
-2
-2
-3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
119.77
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-98.15
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
ST Debt
5
5
5
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
64
65
65
Market Capitalization
5
2
1

Working Capital

FRC

•

in mil. unless spec.
Sep'22
Dec'22
Mar'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
10
10
10
Payables & Accruals
4
5
5
ST Debt
5
5
5
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-14.83%
38.19%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
-149.61%
-91.99%
Sales/Revenue/Turnover
- -
- -
57.47%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
1
2022
- -
1
- -
- -
1
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.02
-0.57
-0.02
- -
-0.45
2022
-0.01
-0.01
-0.01
- -
-0.02
2023
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Brian S. Payne
Full Time Employees
4
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
3295 Quality Way Windsor ON Canada N8T 3R9
IPO Date
May 4, 2020
CIK
0001653821
Website
cenbiotechinc.com
Similar Companies
Talphera, Inc. (TLPH)
Ortin Global Limited (ORTINGLOBE.BO)
Bachem Holding AG (BANB.SW)
AB Science S.A. (AB.PA)
Lords & Company Worldwide Holdings Inc. (LRDS.CN)
BioHarvest Sciences Inc. (CNVCF)
Business
CEN Biotech, Inc. (CENBF) operates as a holding company focused on the manufacture, production, and development of light emitting diode (LED) lighting technology and hemp-based products; it cultivates hemp for industrial, medical, food, and consumer applications including treatments, therapies, nutritional health supplements, and wellness items; and offers digital marketing and web design services. The company, founded in 2013 and headquartered at 3295 Quality Way, Suite 300, Windsor, Ontario, Canada, targets pharmaceutical, biotechnology, healthcare, agriculture, and consumer markets primarily in North America with intentions for global expansion. In recent strategic developments, CEN Biotech closed its acquisition of Clear Com Media Inc. in July 2021, integrating expertise in data analysis, blockchain, media management, and e-commerce to support phyto-medical solutions and long-term growth; it also announced plans for business expansion into global agriculture and health sectors leveraging the acquired technologies.

Company News

APIChat

  • accesswire.com

    CEN Biotech Inc. Announces Planned Strategic Expansion of Business and Closing of Clear Com Media Inc. Acquisition